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1. Introduction
  
 Sponges (Porifera) are vital organisms maintaining 
the ecosystem in the coral  triangle, a world marine 
biodiversity hotspot that includes Indonesia. Sponges 
are sessile organisms that play an important role in 
maintaining coral reef ecosystems and as hosts for 
microbial symbionts such as fungi (Taylor et al. 2007). 
The fungal symbionts in sponges produced diverse 
secondary metabolites that are beneficial for their 
hosts. Sponges utilize fungal secondary metabolites 
for defending against predation and surviving in toxic 
or extreme environmental conditions (Debbab et al. 
2010; Wahl et al. 2012). The association between 
sponges and marine fungi may also produce unique 
and novel natural products potentially beneficial as 
new drugs to overcome medical problems such as 
multidrug-resistant pathogenic microbes, infectious 
diseases, and metabolic diseases (Doshi et al. 2011; 
Pimentel et al. 2011). In 2017, 1490 new natural 
products were reported from marine organisms 
and marine fungi contributed 30% of these new 
natural products (Carroll et al. 2019). However, in 
spite of being one of the great epicenters of marine 
biodiversity, Indonesia has few reports of marine 
fungal secondary metabolites (Hanif et al. 2019).
 Obesity is a common disease occurring in many 
developing countries, including Indonesia. Studies in 
Indonesia reported that as much as 16.5% of children 
and 45.7% of adults are obese (Sari and Amaliah 2014; 
Rachmi et al. 2016), with obesity prevalence higher 
among male children and female adults (Rachmi et 
al. 2017). In general, obesity is treated by limiting 
dietary intake of fat, controlling the absorption 
of dietary fat, and/or controlling the storage and 
metabolism of fat and glucose in the body. Several 
drugs have been developed for anti-obesity, such 
as sibutramine, lorcaserin, rimonabant, and orlistat. 
However, adverse effects have been reported for each 
of these drugs. 
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This study aimed to evaluate the potential of marine fungus Purpureocillium 
lilacinum isolated from an Indonesian marine sponge Stylissa sp. as an anti-
obesity agent through pancreatic lipase inhibition assay. The fungus was identified 
as P. lilacinum through morphological and molecular characteristics. The fungal 
extract’s inhibition activity and kinetics were evaluated using spectrophotometry 
and Lineweaver-Burk plots. Ethyl acetate and butanol were used for extraction. 
Both extracts showed pancreatic lipase inhibition in a concentration-dependent 
manner. Both crude extracts were then fractionated once. All fractionated extracts 
showed inhibitory activity above 50%, with the highest activity found in fraction 
5 of ethyl acetate at 93.41% inhibition. The best fractionated extract had an IC50 
value of 220.60 µg.mL-1. The most active fraction of P. lilacinum had a competitive-
type inhibitor behavior as shown by the value of Vmax not significantly changing 
from 388.80 to 382.62 mM pNP.min-1, and the Michaelis-Menten constant (KM) 
increased from 2.02 to 5.47 mM in the presence of 500 µg.mL-1 fractionated 
extract. Metabolite identification with LC-MS/MS QTOF suggested that galangin, 
kaempferol, and quercetin were responsible for the observed lipase inhibition.
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 Sibutramine, a centrally acting phenethylamine 
class of drug used for long-term treatment of obesity 
in adults, reduces food intake by selective inhibition 
of the re-uptake of noradrenaline, serotonin, and 
dopamine, resulting in thermogenesis and lipolysis. 
Common side effects of sibutramine are due to 
activation of the sympathetic nervous system and 
include dry mouth, insomnia, constipation, headache, 
anorexia, hypertension, and increased pulse rate 
(Elangbam 2009). Lorcaserin, a selective 5-HT2C 
receptor agonist located in various parts of the brain 
and hypothalamus, has serotonergic properties 
which act as an anorectic resulting in weight loss 
through hypophagia (Lam et al. 2008). Rimonabant, 
an appetite suppressant, blocks the cannabinoid-1 
(CB1) receptors, and thus decrease demand for food. 
Rimonabant side effects include mood changes, 
nausea and vomiting, diarrhea, headache, dizziness, 
and anxiety (Kaila and Raman 2008).
 In contrast, as the most accepted drug by the 
FDA for obesity treatment, orlistat is a hydrogenated 
derivative of lipstatin produced by Streptomyces 
toxytricini and acts by diminishing the absorption 
of dietary fat by inhibiting pancreatic lipase activity. 
Orlistat is an irreversible inhibitor targeting the active 
site of pancreatic and gastric lipase, binds covalently 
to the serine residue on the active site preventing the 
intraluminal hydrolysis of triglyceride and resulting 
in an increase in fecal fat excretion (Heck et al. 2000). 
Drugs with covalent inhibitory mechanism of action 
provides many pharmacological advantages over 
drugs with reversible mechanism of action; these 
advantages include enhanced potency, selectivity, 
and prolonged activity (Singh et al. 2011).
 Despite the great potential of covalent inhibition, 
there are several potential downsides and limitations 
of this drug class. The longer residence time of 
these drugs can lead to toxicity which can generate 
adverse clinical outcomes if these drugs are used 
long-term (De Cesco et al. 2017). Orlistat is reported 
to deliver adverse effects, including liquid stools, 
steatorrhea, fat-soluble vitamin deficiencies, fecal 
urgency, and flatus incontinence (Kaila and Raman 
2008). If consumed long-term, orlistat may cause 
hepatotoxicity, gallstone formation, kidney stones, 
and acute pancreatitis (Katoch et al. 2017). There has 
been a great interest among researchers in finding 
pharmacologically active molecules with fewer side 
effects.
 The marine sponge Xestospongia testudinaria 
from China has been found to produce the 
pancreatic inhibitor xestonariena I from an unknown 
biosynthetic pathway (Yang et al. 2017). Several 
marine fungi from the Aspergillus group associated 
with a marine sponge from the South China Sea 
were also reported to be a source of pancreatic lipase 
inhibitors, such as flavipesides A−C from Aspergillus 
flavipes 164013 isolated from a marine sponge 
Dysidea sp. and petrosamides A-C from Aspergillus 
sp. 151304 associated with marine sponge Petrosia sp. 
(Jiao et al. 2020; Tang et al. 2020). The biodiversity 
of marine fungi and their potential in Indonesia are 
high. However, research on sponge-associated marine 
fungi in Indonesia and their potential as a source of 
anti-obesity metabolites has not been carried out. We 
began our research to fill this gap. The main objective 
of this research was to investigate marine sponge-
associated fungi as secondary metabolite producers 
to inhibit pancreatic lipase activity to potentially 
treat obesity.
2. Materials and Methods
2.1. Marine Fungal Isolation 
 Purpureocillium lilacinum IPBCC.19.1498 was 
isolated from a marine sponge Stylissa sp. collected 
from Pramuka Island, Seribu Archipelago, Jakarta, 
Indonesia. Fungal isolation was carried out as 
follows: the sponges were cut and collected into a 
sterile container at depths of ±10 m underwater to 
prevent contact of tissue with air. Then, the samples 
were stored at 4°C prior to fungal isolation at the 
laboratory. The sample was surface sterilized with 
sterile water prior to fungal isolation by a direct 
isolation method following Zhang et al. (2009) with 
slight modification. Samples were cut into large 
pieces and separated based on cuts such as an outer 
layer, middle layer, and inner layer of sponges. Then, 
the big pieces were rinsed three times with sterile 
water and cut further into small pieces of 1 cm3. The 
pieces were then planted into potato dextrose agar 
(PDA) with 75% seawater. The medium also contained 
chloramphenicol antibiotic (500 mg.L-1) and rose 
bengal fungistatic (30 mg.L-1) and then incubated at 
27°C for a month. The fungal isolation was done by 
planting three pieces of sample in each petri dish and 
was done in three replicates. The fungi that emerge 
from the samples' pieces were transferred onto new 
medium to obtain pure cultures.
2.2. Morphological and Molecular Analysis of 
Fungi 
 The morphological identification followed the 
method reported by Luangsa-Ard et al. (2011). 
In brief, the fungus was grown on PDA at 27°C 
and incubated for seven days. The morphological 
and micromorphological features such as colony 
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characteristics, conidiophores, phialides, and conidia 
were measured.
 The fungal genome DNA was isolated following the 
method of Sambrook et al. (1989). Briefly, the fungal 
isolates were cultured on cellophane membrane on 
PDA at 27°C for five days prior to cell harvesting for 
genome DNA extraction. The mycelium was harvested 
and ground with a sterile pestle. Fungal genome DNA 
was extracted using the cetyl trimethyl ammonium 
bromide (CTAB) buffer lysis solution followed by 
washing with phenol-chloroform-isoamyl alcohol 
(PCI) mixture and precipitated with ethanol. The DNA 
quality was measured with nanodrop.
 The fungal genome DNA was used in PCR as a 
template to amplify the fungal ITS rDNA region 
using primers ITS1 and ITS 4 (White et al. 1990). The 
reaction mixture contained 12.5 µl PCR master mix 
(kappa fast 2G), 1.5 µl of 10 pmol primer (each), 3 
µl of 100 ng DNA template and 6.5 µl NFW. PCR 
conditions were as follows: initial denaturation (94°C 
for 5 min); 30 cycles of denaturation (94°C for 30 s), 
primer annealing (55°C for 1 min), and elongation 
(72°C for 2 min), with a final elongation at 72°C for 10 
min. PCR products were purified prior to sequencing 
analysis. The sequencing result was then analyzed for 
its homologous sequences within the GenBank and 
MycoBank databases by using the program Basic Local 
Alignment Search Tool (BLAST) at http://blast.ncbi.
nlm.nih.gov. Phylogenetic trees were constructed by 
using MEGA 6.0 program.
2.3. Fungal Extract Production  
 Fungal extract and fractionated extract were 
conducted following protocols by Ebadda et al. (2008) 
and Kjer et al. (2010). The fungus was cultivated in PDA 
with 75% seawater without antibiotic. Plugs of agar 
supporting mycelium growth were transferred to 3 l 
of potato dextrose broth (PDB) medium. Flasks were 
incubated at 27°C in constant shaking at 150 rpm for 
seven days. The broth culture was then harvested by 
separating from mycelia. 
 The crude extract was obtained by extracting 
broth culture gradually using ethyl acetate followed 
by n-butanol as organic solvent and evaporated 
under vacuum. The extracts were chromatographed 
on Silica and XAD resins with gradient eluent to give 
extract fractions. The dried crude extract and the 
fractionated extract were reconstituted in DMSO for 
further analysis. 
2.4. Assay of Inhibitory Effect on the Pancreatic 
Lipase Activity
 Lipase activity was determined by measuring 
p-nitrophenol (pNP) concentration released from 
the activity between lipase and p-nitrophenyl 
butyrate (pNPB). The activity was measured by 
spectrophotometry following procedures from 
Chedda et al. (2016) with slight modification for 
absorbance measurements optimizations. Total assay 
volume was 200 µl containing 25 µl of 500 µl.mL-1 
pNPB, 50 µl of 200 µg.mL-1 porcine pancreatic lipases, 
and 25 µl sample in dimethyl sulfoxide (DMSO). The 
reaction was brought to 200 µl with 100 mM pH 7.2 
phosphate buffer saline (PBS). The test solution was 
incubated for 30 minutes at 37°C prior to measuring 
pNP at 400 nm using an ELISA plate reader (Biotek). 
The sample was assayed in three replicates, and 
the results were reported as a mean of replicates 
measurements.
 The percentage of inhibitory activity was 
calculated using the following formula:
 The absorbance of blank and absorbance of the 
sample were corrected by measuring the activity 
without using enzyme in the assay mixture. Orlistat 
was used as the positive control. The test was done 
in every step of bioactivity monitoring of fungal 
extract. The fractionated extract with the greatest 
inhibitory activity was then selected and subjected to 
IC50 and inhibition kinetics assay. This selected most 
active fractionated extract was diluted with DMSO 
in various concentrations to prepare the required 
inhibitor concentration used in the IC50 assay.
2.5. Inhibition Kinetics of Selected 
Fractionated Extract
 The substrate stock solution of pNPB was prepared 
freshly in acetonitrile (1 µl.mL-1). The stock was then 
diluted with phosphate buffer to prepare the required 
concentrations between 2.3 to 6.0 mM. The inhibition 
kinetics of the most active fractionated extract were 
carried out by measuring assay mixtures with various 
substrate concentrations and incubated at 37°C for 
1 hour. The mixtures were measured for every 5 
minutes of incubation to obtain the enzyme activity 
rate across multiple substrate concentrations. 
2.6. Metabolites Identification by LC-MS/MS 
QTOF Screening
 The most active fractionated extract was 
then subjected to LC-MS/MS QTOF to screen the 
metabolites present in the extract. The screening 
criteria was selected from flavonoid, alkaloid, 
tannin, steroid, saponin, and triterpenoid groups. 
The screening was required to meet four criteria to 
% Inhibition = 
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ensure the metabolites were present in the extract. 
The criteria were as follows:
 - Mass error ≤ 5 ppm
 - Isotope match MZ RMS PPM ≤ 6 ppm and isotope 
    match MZ RMS % ≤10 %
 - Intensity/Response ≥300 
 - Fragment match ≥1 mass fragment
3. Results
3.1. Fungal Isolation and Identification
3.1.1. Fungal Isolation and Morphological 
Characteristics
The fungus was successfully isolated from the 
middle layer of the Stylissa sp. sponge. The fungus 
was found grown in two pieces of the sponges. The 
fungus was identified as Purpureocillium lilacinum 
IPBCC.19.1498 based on morphological characteristics 
(Figure 1). The fungal characteristics were as follows. 
Colonies at 27°C on PDA (Oxoid) attained 17.00-
18.47 mm diameters after seven days of incubation. 
Colonies consisted of basal felt of numerous 
conidiophores with a floccose overgrowth of aerial 
mycelium, purple in color; reverse colony mostly 
in shades of purple. Somatic hyphae were hyaline, 
smooth-walled, 1-3 µm wide. Conidiophores were 
up to 100 µm long; stalks with roughened thick walls 
3–6 µm wide consisting of verticillate branches with 
whorls of 2–4 phialides. Conidiophores sometimes 
grew irregularly branched, septate, hyaline and 
smooth-walled. Phialides were 7–15 × 2–3 µm, 
having a swollen basal portion tapering into a short 
distinct neck about 1 µm wide. Conidia were in long 
dry chains, ellipsoidal to fusiform, 2–3 × 2–4 µm, 
smooth-walled, mostly subhyaline, chlamydospores 
absent. 
3.1.2. Molecular Analysis of Fungi 
Further identification using molecular features 
showed that the identification result with BLAST 
analysis is in agreement with that of the morphological 
analysis. The fungus has 100% similarity with P. 
lilacinum (AB_103380). The results of the phylogenetic 
analysis supported that of the BLAST analysis. The 
phylogenetic tree of the fungus was constructed with 
the maximum likelihood method based on the Tamura 
3-parameter model by using MEGA 6.0 program, and 
a total of 17 OTU were used in the analysis of ITS rDNA 
sequences with Paracremonium binnewijzendii CBS 
143277 as an outgroup (Table 1). The dataset consists 
of 665 nucleotide characters for the analyses, 479 
were constant and 186 were variable.
The Maximum likelihood analysis inferred by 
Tamura 3-parameter model yielded the highest 
likelihood value -1689.9489 shown in Figure 2. A 
discrete gamma distribution was used to model 
evolutionary rate differences among sites (5 categories 
(+G, parameter = 0.2150)). The tree is drawn to scale, 
with branch lengths measured in the number of 
substitutions per site. Bootstrap values above 50% are 
indicated above branches. A bootstrap value greater 
than 70 % is considered strong. The phylogenetic tree 
constructed showed that P. lilacinum IPBCC.19.1498 is 
in the same cluster with P. lilacinum AB_103380 with 
bootstrap value 99% and sisters to P. lavendulum CBS 
128677 with 99% bootstrap value.
Figure 1. Colony and microscopic structures of 
Purpureocillium lilacinum IPBCC.19.1498 
grown on PDA at 7 days after inoculation. 
(A-B) IPBCC.19.1498 sporulating colonies on 
dark and light backgrounds at 27°C, (C-D) 
conidiophore, (E) branched conidiophore, (F) 
phialides, (G) typical fusiform conidia. Scale 
bars are 1 cm (A-B) and 10 µm (C-G).
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Table 1. ITS rDNA of organisms used in phylogenetic tree construction


















































Figure 2. Phylogenetic tree of ITS rRNA gene obtained by maximum likelihood analysis. Phylogenetic analysis was performed 
on the basis of 665 unambiguously aligned positions of ITS rRNA gene with Paracremonium binnewijzendii as 
outgroup. Bootstrap values are indicated at the nodes 
3.2. In Vitro Inhibitory Pancreatic Lipase 
and Assay of Purpureocillium lilacinum 
IPBCC.19.1498 Extract
The inhibitory effect of P. lilacinum IPBCC.19.1498 
crude extracts on pancreatic lipase activity is 
presented in Figure 3. Both P. lilacinum IPBCC.19.1498 
ethyl acetate and butanol extracts inhibited the 
activity of pancreatic lipase in a dose dependent 
manner. The extracts show increased inhibition 
with increased extract concentration from 250 to 
1,000 µg.mL-1. The inhibitory activity observed for 
both extracts shows the inhibitory concentration 50 
(IC50) value was between 250 to 500 µg.mL
-1 of crude 
extract. 
Both extracts were then chromatographed in silica 
and XAD resins and subjected to the gradual polarity 
of eluent to obtain 12 fractionated extracts separated 
based on eluent used. All fractionated extracts from 
ethyl acetate and butanol showed inhibitory activity 
above 50%, with the highest activity found in fraction 
5 of ethyl acetate extract and fraction 12 of butanol 
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Fraction 5 of ethyl acetate extract was chosen 
as the most active fractionated extract for IC50 and 
enzyme kinetics analyses. The IC50 can be determined 
by constructing a dose-response curve and examining 
the effect of different concentrations of inhibitors on 
enzyme activity. The IC50 value is determined by the 
concentration needed to inhibit half of the maximum 
enzymatic response. IC50 values can also be used to 
compare the potency of inhibitors. In this study, the IC50 
value was measured under different concentrations of 
the best-fractionated extract and orlistat as the positive 
control (data not shown). The most active fractionated 
extract had efficacy of 61.75% at 500 µg.mL-1 and an IC50 
of 220.60 µg.mL-1; meanwhile, orlistat as positive control 
had IC50 of 30.57 µg.mL
-1.
3.3. Kinetic Behavior of Best-fractionated Extract
 The reaction rates of the most active fractionated 
extract are shown in Figure 5. The most active fractionated 
ethyl acetate extract of P. lilacinum had a competitive-type 
behavior on inhibition of pancreatic lipase based on the 
maximum rate (Vmax) not significantly changing, and the 
enzyme constant (KM) increasing from 2.02 mM to 5.47 
mM. The increased value of KM means the presence of 
substrate reduces the inhibitory activity of the extract. 












concentration of Purpureocillium lilacinum extract (µg.mL-1)
n-butanol
Figure 3. Effect of Purpureocillium lilacinum crude extracts on pancreatic lipase activity. Extract of ethyl acetate and 












Figure 4. Effect of Purpureocillium lilacinum fractionated extracts of ethyl acetate and butanol on pancreatic lipase activity. 
All fractionated extracts were measured thrice. Values are inhibition (%) converted from means of pNP absorbance
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3.4. Fungal Metabolites Identification by LC-
MS/MS QTOF Screening
 The metabolite screening of the most active 
fractionated P. lilacinum extract by LC-MS/MS QTOF 
showed 33 metabolites dominated by flavonoids, 
tannins, and terpenes. Three out of the identified 
metabolites are reported as lipase inhibitors, 
namely: galangin, kaemferol, and quercetin. The 
characteristics of the three predicted metabolites are 
presented in Table 3.
Table 3. Predicted metabolites identified with LC-MS/MS QTOF from the most active fractionated extract of Purpureocillium 











































Table 2. Kinetic parameters of pancreatic lipase in the 
presence of the most active fractionated extract 
as inhibitor















Figure 5. Substrate transformation in the presence and absence of the most active fractionated extract of Purpureocillium 
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4. Discussion
 The fungus was identified as Purpureocillium 
lilacinum IPBCC.19.1498 based on morphological and 
molecular characteristics, including the phylogenetic 
tree. The fungus obtained in this study is in the same 
clade with soil fungus P. lilacinum (AB_103380) with 
a bootstrap value of 99%. The genus Purpureocillium is 
proposed by Luangsa-Ard et al. (2011) for Paecilomyces 
lilacinus, along with Paecilomyces nostocoides, Isaria 
takamizusanensis, and Nomuraea atypicola, which 
belongs to Ophiocordycipitaceae based on the 
phylogenetic analysis of the 18S rRNA. The genus was 
proposed because the type species of Paecilomyces, P. 
variotii, is located in the family of the Trichocomaceae 
(Eurotiales) near Aspergillus, Penicillium and related 
species, forming a sister clade with the Onygenales 
(Luangsa-Ard et al. 2004; Sung et al. 2007; Luangsa-
Ard et al. 2011).
 Purpureocillium lilacinum is commonly reported 
as a terrestrial fungus, commonly occurring as 
a saprobic species isolated from soil, decaying 
vegetation, insects and insect larvae, nematodes, 
and other animals. Although widely reported as a 
component of the soil mycobiota, several strains 
were reported to cause keratitis typically occurring 
by external invasion (Domniz et al. 2001; Yuan et al. 
2009). It has also been reported that P. lilacinum has 
been isolated from deep seawater samples in China 
and associated with a sponge from Malaysia (Cui et al. 
2013; Mosadeghzad et al. 2013). But none have been 
reported from Indonesia. 
 Purpureocillium lilacinum is categorized as a 
facultative marine fungi since the fungus has the 
ability to grow on medium without sea water. 
Therefore, there is the possibilty the fungus was 
carried from land by streams and rivers into the sea 
and filtered by sponges. The capacity of P. lilacinum 
to colonize substrates under harsh conditions with 
low nutrient concentrations and low oxygen levels 
suggests that this species is able to survive in sea 
water (Mountfort and Rhodes 1991; Vigueras et 
al. 2008). Moreover, strains of Purpureocillium sp. 
have been reported to survive in a wide range of 
temperatures and pH, which allows them to grow in 
a variety of substrates and makes them a rich source 
of biologically active natural products (Mosadeghzad 
et al. 2013). Purpureocillium lilacinum was frequently 
found in water distribution systems, including water 
tanks, sinks, showers (including drains), toilets, and 
air in a three-year study by Anaissie et al. (2003). The 
fungi can survive in water distribution systems and 
form a biofilm with other genera such as Aspergillus, 
Fusarium, and Acremonium (Anaissie et al. 2003). 
 Numerous kinds of marine fungi have been reported 
to produce diverse secondary metabolites with potential 
as medicine for many diseases. Purpureocillium 
lilacinum has produced diverse metabolites with unique 
properties such as α-pyrone analogue phomaligol A, 
exhibiting antibacterial activity against Staphylococcus 
aureus, methicillin-resistant S. aureus and multidrug-
resistant S. aureus, leucinostatin A and B as antibacterial, 
antifungal, and antitumor agent, and caused uncoupling 
effect on rat liver mitochondrial function. Other 
metabolites such as phomapyrone C also showed anti-
bacteria activity against Acinetobacter baumannii, and 
1,2-dilinolylglycero-O-4’-(N,N,N-trimethyl)homoserine, 
methyl myristate and cerebroside B–D inhibited the 
human cancer K562, MCF-7, HL-60, and BGC-823 cell 
lines. Purpureocillium lilacinum also reported to produce a 
pyridone alkaloid, paecilomide as acetylcholine esterase 
inhibitor, and cerebrosides A showed nematicidal 
activity against Bursaphelenchus xylophilus (Arai et al. 
1973; Fukushima et al. 1983; Elbandy et al. 2009; Yang 
et al. 2011; Cui et al. 2013; Teles and Takahashi 2013). 
The present study is the first report of P. lilacinum 
marine fungus associated sponge showing inhibitory 
effects on pancreatic lipase enzyme activity.
 Pancreatic, endothelial, hepatic, lipoprotein 
lipases are human lipases that possesses structural 
similarity. Other tissues like lungs, kidneys, skeletal 
muscles, adipose tissue and placenta also secrete 
lipase enzymes. Pancreatic acinar cells secrete 
pancreatic lipase (triacylglycerol acyl hydrolase 
EC 3.1.1.3), an essential enzyme of pancreatic juice 
responsible for digestion, responsible for about 70% of 
triglyceride breakdown and absorption from dietary 
fat into the small intestine. Therefore, pancreatic 
lipase inhibitors are used for medication to treat 
obesity (Mukherjee 2003; Liu et al. 2020). 
 The IC50 value of pancreatic lipase inhibition with 
most active fractionated extract of P. lilacinum was 
220.60 µg.mL-1 while orlistat was 30.57 µg.mL-1. The 
potencies of several plant crude extracts reported to 
inhibit pancreatic lipase show IC50 values between 
200 to 500 µg.mL-1 such as Nelumbo nucifera and 
Salacia reticulata at 460 µg.mL-1 and 264 µg.mL-1, 
respectively (Birari and Bhutani 2007). Several plants 
extract used as slimming agents in jamu, namely 
Zingiber cassumunar, Guazuma ulmifolia, Tamarindus 
indica, Murraya paniculata, and Kaempferiae rotundae 
had been reported to have pancreatic lipase 
inhibitory activity. The activity of ethanol extract of 
Z. cassumunar, G. ulmifolia, and T. indica were 29.17% 
for 100 µg.mL-1, 25.13% for 60 µg.mL-1, and 49.0% for 
150 µg.mL-1, respectively. The activity of water extract 
of M. paniculata was 25.66% for 100 µg.mL-1 and K. 
rotundae was 65.1% for 200 µg.mL-1 (Iswantini et 
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al. 2011, Pradono et al. 2011). Methanolic extract of 
several species used as medicinal plants in Korea also 
showed varied efficacy. Three of these plants were 
reported to have the highest efficacy, namely Eriochloa 
villosa (83%), Orixa japonica (81.3%), and Setaria italica 
(80.3%) at 200 µg.mL-1 extract concentrations (Sharma 
et al. 2005). Therefore, the extract of P. lilacinum in 
this study may potentially inhibit pancreatic lipase 
and could be categorized as a good source of inhibitor, 
similar to plant extracts mentioned above. Although 
the extract in this study had been fractionated once, 
the extract showed promising result. 
 The value of the Vmax was not significantly changed 
from 388.8 mM pNP.min-1 to 382.62 mM pNP.min-1, 
and the Michaelis-Menten constant (KM) increased 
from 2.02 mM to 5.47 mM in the presence of 500 
µg.mL-1 fractionated extract. The Vmax value showed a 
saturated state where the enzymes were fully occupied 
with the substrate in the active site. In contrast, the 
Michaelis-Menten constant showed a stable enzyme-
substrate complex where half of the Vmax condition 
was achieved. The KM value also showed an affinity 
of the enzyme for substrate. A lower KM value shows 
a higher enzyme affinity to the substrate (Nelson and 
Cox 2017). Therefore, the competitive type inhibition 
exhibits an increasing value of KM, which means that 
the substrate loses the affinity with the enzyme in 
the presence of the inhibitor. Thus, the most active 
fractionated extract of P. lilacinum is a competitive-
type inhibitor.
 A competitive inhibitor binds to the enzyme's 
active site and prevents the substrate from binding 
to that active site. A reversible competitive inhibitor 
diminishes the rate of catalysis by reducing the 
proportion of enzyme molecules bound to a substrate. 
At any given inhibitor concentration, competitive 
inhibition can be relieved by increasing the substrate 
concentration. With increased concentration, the 
substrate can outcompete the inhibitor for the active 
site (Berg et al. 2002). Meanwhile, with orlistat as an 
irreversible inhibitor, the enzyme-inhibitor complex 
is permanently unable to function as an enzyme and 
only production of new enzyme will allow reaction 
of the substrate. The irreversible inhibitor cannot be 
overcome by increasing the substrate concentration. 
The residence time of an irreversible inhibitor for 
pancreatic lipase in the intestinal lumen may lead to 
an unwanted effect in the body such as liquid stools, 
steatorrhea, fat-soluble vitamin deficiencies, fecal 
urgency, and flatus incontinence since there is a need 
to produce fresh enzyme to replace the inhibited 
lipase. The present study is the first step and exhibits 
the results of in vitro experiments, however it shows 
that P. lilacinum extract may become a potential 
source of metabolites to develop an anti-obesity drug 
with a competitive inhibitory mechanism.
 Metabolite identification by LC-MS/MS QTOF 
revealed 33 metabolites dominated by flavonoids, 
tannins, and terpenes. Flavonoids and terpenes are 
two molecular groups known to inhibit pancreatic 
lipase (Birari and Bhutani 2007). The three identified 
metabolites, galangin, kaempferol, and quercetin, 
are known lipase inhibitors. Therefore, these three 
metabolites could be responsible for inhibiting 
pancreatic lipase in the most active fractionated 
extract assessed in this study.
 In conclusion, the Indonesian marine fungus 
associated with Stylissa sp. sponges produced 
potential secondary metabolites with pancreatic 
lipase inhibition in in vitro tests and was isolated 
and identified as P. lilacinum IPBCC.19.1498.  The 
fungal compounds were extracted from the culture 
broth using ethyl acetate and butanol, and the most 
active fractionated extract was obtained from ethyl 
acetate. The most active fractionated extract had 
an IC50 value of 220.60 µg.mL
-1. The IC50 value of the 
most active fraction  obtained from the crude extract 
was eight times higher than the orlistat as positive 
control. The present study also revealed that the 
most active fractionated extract of P. lilacinum had 
a competitive inhibitory mechanism. Metabolite 
screening of the most active fractionated extract 
suggested the presence of three metabolites known 
to be responsible for pancreatic lipase inhibition, 
namely galangin, kaempferol, and quercetin.
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